David K. Miller is a global marketing executive and genomics strategist with over 20 years of experience spanning scientific research and commercial leadership. Currently Vice President of Global Marketing at PacBio, he leads a global organisation across product marketing, customer support, and training. In this role he led the launches of breakthrough platforms such as Revio and Vega.

Before entering the commercial sector, David built his career in academic genomics, contributing to foundational projects in pancreatic and ovarian cancer genomics as part of Australia’s participation in the International Cancer Genome Consortium (ICGC)—then the country’s largest biomedical research initiative. His work helped sequence over 500 cancer genomes, advancing the molecular understanding of treatment-resistant cancers. He also led efforts to establish Australia’s first accredited clinical whole-genome sequencing service at Garvan Institute, supporting diagnostic advances in rare inherited diseases.

David has co-authored over 55 peer-reviewed publications, with more than 13,800 citations, including work published in Nature and PLoS ONE. His research spans whole-genome sequencing, allele-specific expression, and translational genomics for clinical impact.